Status:
UNKNOWN
Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19)
Lead Sponsor:
Texas Cardiac Arrhythmia Research Foundation
Conditions:
COVID-19
Eligibility:
All Genders
18-85 years
Phase:
PHASE1
Brief Summary
This study is designed to compare the efficacy of detection of COVID-19 infection using the serology test in blood sample and the PCR-based test in the nasopharyngeal (NP) and sputum sample. Furthermo...
Detailed Description
The investigators hypothesize that viral-RNA test using sputum will be equally efficient as the test performed in NP swab. Moreover, the serology test and the PCR-based test will be comparable in effi...
Eligibility Criteria
Inclusion
- • Male or female over 18 years of age at the time of enrollment
- Current symptoms of COVID-19 ; fever alone or fever and at least one of the following symptoms need to be present
- Dry cough
- Sore throat
- Shortness of breath
- Chills
- Muscle pain
- Headache
- New loss of taste or smell
- Chills with repeated shaking
Exclusion
- • Unwilling to provide informed consent
- Unwilling to undergo bi-weekly serological test during the 1-month enrollment
Key Trial Info
Start Date :
May 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04372004
Start Date
May 8 2020
End Date
June 1 2021
Last Update
August 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Texas Cardiac Arrhythmia Institute
Austin, Texas, United States, 78705